Bartonella Treatment

Methylene blue is presented as having partial but notable stationary-phase activity against Bartonella. Standard antibiotics are presented as most effective during Bartonella log phase. Bartonella is described as treatment-resistant partly because of heavy biofilm production. Stationary-phase Bartonella is described as bacteria that have stopped rapid replication, formed biofilm, and become antibiotic-resistant persister cells. Longstanding chronic tick-borne illness is typically associated with stationary-phase infection. Daptomycin plus doxycycline plus septrin is described as a combination approach for persister infections. Rifampin is described as best for actively replicating log-phase Bartonella. Dapsone-containing sulfa drug therapy is presented as most effective for chronic or stationary-phase Bartonella.